Heliospectra AB (OTCQB:HLSPY, FIRSTNORTH: HELIO), a world leader in intelligent lighting technology for greenhouse cultivation and plant research, is pleased to announce that Dr. Suzanne Sisley will be presenting at the upcoming National Cannabis Summit and Heliospectra will be exhibiting in Booth #123. The event will take place on October 12-13 at the Sheraton Denver Downtown, Denver, Colorado.
Dr. Suzanne Sisley, M.D. Director of Medical Plant Research at Heliospectra, will be speaking on Monday, October 12 at 4:00 pm on the topic “Barriers of Marijuana Research / Veterans PTSD Cannabis Study”.
Dr. Sisley practices medicine in Scottsdale, AZ and specializes in Internal Medicine and Psychiatry. She is widely known for her research into potential medical uses of marijuana to treat veterans diagnosed with Post-Traumatic Stress Disorder – PTSD. Dr. Sisley’s research is supported by the Multidisciplinary Association for Psychedelic Studies (MAPS), a California-based nonprofit organization. In February this year Dr. Sisley was also appointed Director of Medicinal Plant Research at Heliospectra AB. Where her groundbreaking research will help customers understand what chemical profiles a medicinal plant therapy should express, and how to develop scalable medicinal plant growing methodologies.
The National Cannabis Summit is set on taking cannabis conferences to a new level by setting the future standard of cannabis business conferences. For this to happen MJ Conferences, an event management company, has paired together with Weedstock and Tribal Hemp & Cannabis Education. The event will feature a diverse series of panels, forums and speakers from three key parts of the cannabis industry; Business, Investor and Native American Involvement.
For further information regarding this event, please click on the following link: https://www.nationalcannabissummit.com/
About Heliospectra AB
Heliospectra AB (OTCQB: HLSPY, FIRSTNORTH: HELIO) (www.heliospectra.com) specializes in intelligent lighting technology for plant research and greenhouse cultivation. The Company’s lighting system provides an effective and durable technology for cultivating greenhouse and indoor plants by combining several different groups of versatile light emitting diodes (LEDs) with optics, remote sensing techniques, and a robust heat dissipation solution. This proprietary setup gives growers the ability to control the intensity and wavelengths of the light emitted, creating a spectrum specifically adjusted to different plant species and growth stages to better facilitate photosynthesis. The complete, highly-engineered lamp produces crops that look better, taste better, and have a longer shelf-life than those grown under HID lamps. The technology not only reduces energy consumption by up to 50%, but also helps stimulate growth characteristics and improve plant quality. Other benefits include reduced light pollution, lower mercury use due to the avoidance of traditional HID/HPS bulbs, and less HVAC investment and monthly expense requirements.
Heliospectra products are based on in-depth knowledge in plant physiology and photosynthesis along with a unique way to utilize modern LED technology. After six years of development in Sweden, the company has now begun to expand into the international market. The company has raised more than $ 18 million in capital and has received more than $2.6 million through academic scholarships and grants. It has also received numerous awards for its forward thinking technology. Principal owners: Weland Steel www.welandstal.se, Swedish Industrial Fundwww.industrifonden.se, Midroc www.midroc.se, Wood & Hill Investment www.whab.se
Forward-Looking Statements
The statements in this press release constitute forward-looking statements within the meaning of federal securities laws. Such statements are based on our current beliefs and expectations and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond our control. In addition, such forward-looking statements are subject to assumptions with respect to future business strategies and decisions
Contact
Investor Relations:
Michael Swartz, Senior Analyst | Viridian Capital Advisors, LLC | Tel: 212-333-0257 | Email: [email protected]
Staffan Hillberg, CEO | Heliospectra AB | Tel: +46-708-36 59 44 | Email:[email protected]
